ALX ONCOLOGY HOLDINGS INC

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

ALXO$1.29+11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	September 30,	December 31,
	2024	2023
Assets
Current assets:
Cash and cash equivalents	$16,102	$22,406
Short-term investments	132,472	160,330
Prepaid expenses and other current assets	7,321	5,923
Total current assets	155,895	188,659
Property and equipment, net	3,112	3,589
Long-term investments	14,036	35,411
Other assets	12,672	14,894
Total assets	$185,715	$242,553
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$7,891	$8,591
Payable and accrued liabilities due to related party	63	543
Accrued expenses and other current liabilities	24,386	26,867
Total current liabilities	32,340	36,001
Term loan, non-current	9,835	9,639
Other non-current liabilities	6,733	7,201
Total liabilities	48,908	52,841
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.001 par value; 1,000,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 52,743,104 and 49,951,989 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	53	50
Additional paid-in capital	728,150	675,678
Accumulated other comprehensive income (loss)	563	256
Accumulated deficit	(591,959)	(486,272)
Total stockholders’ equity	136,807	189,712
Total liabilities and stockholders’ equity	$185,715	$242,553

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.